Xilio Therapeutics, Inc. (XLO)
9.08
+0.07
(+0.78%)
USD |
NASDAQ |
Oct 09, 16:00
9.08
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Price : 9.08 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 9.01 | 9.14 | 8.775 | 9.01 | 20786.00 |
| Oct 07, 2026 | 9.00 | 9.01 | 9.00 | 9.01 | 885.00 |
| Oct 06, 2026 | 9.10 | 9.32 | 8.81 | 9.00 | 6198.00 |
| Oct 05, 2026 | 9.07 | 9.49 | 9.07 | 9.11 | 7158.00 |
| Oct 02, 2026 | 8.89 | 9.075 | 8.89 | 9.01 | 7400.00 |
| Oct 01, 2026 | 8.97 | 9.12 | 8.79 | 8.91 | 12886.00 |
| Sep 30, 2026 | 9.19 | 9.25 | 9.05 | 9.05 | 5378.00 |
| Sep 29, 2026 | 9.568 | 9.568 | 8.938 | 8.938 | 3115.00 |
| Sep 28, 2026 | 9.21 | 9.22 | 8.96 | 9.05 | 11128.00 |
| Sep 25, 2026 | 9.00 | 9.21 | 8.93 | 9.04 | 3418.00 |
| Sep 24, 2026 | 8.93 | 9.09 | 8.93 | 9.00 | 16006.00 |
| Sep 23, 2026 | 9.03 | 9.04 | 8.94 | 8.94 | 1276.00 |
| Sep 22, 2026 | 9.04 | 9.16 | 8.950 | 9.04 | 6877.00 |
| Sep 21, 2026 | 8.96 | 9.175 | 8.96 | 9.02 | 7132.00 |
| Sep 18, 2026 | 8.995 | 9.67 | 8.94 | 9.13 | 22936.00 |
| Sep 17, 2026 | 9.00 | 9.049 | 8.93 | 9.04 | 14463.00 |
| Sep 16, 2026 | 9.02 | 9.02 | 8.93 | 8.98 | 11533.00 |
| Sep 15, 2026 | 8.930 | 9.03 | 8.930 | 9.03 | 17350.00 |
| Sep 14, 2026 | 9.06 | 9.21 | 8.93 | 8.93 | 10262.00 |
| Sep 11, 2026 | 8.93 | 9.49 | 8.93 | 8.93 | 5147.00 |
| Sep 10, 2026 | 8.95 | 9.00 | 8.93 | 8.93 | 11800.00 |
| Sep 09, 2026 | 8.91 | 9.00 | 8.800 | 8.97 | 8983.00 |
| Sep 08, 2026 | 9.03 | 9.11 | 8.81 | 8.91 | 9994.00 |
| Sep 04, 2026 | 9.231 | 9.231 | 8.81 | 9.00 | 7643.00 |
| Sep 03, 2026 | 8.94 | 9.10 | 8.721 | 9.02 | 6571.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cue Biopharma, Inc. | 27.82 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| PS Ratio | 2.085 |
| Price to Book Value | 0.8268 |
| Earnings Yield | -18.57% |
| Market Cap | 59.75M |